Figure 2.

Guideline‐recommended heart failure therapy use: (A) beta‐blockers, (B) renin–angiotensin system inhibitors, and (C) mineralocorticoid receptor antagonists, in the CHAMP‐HF and CHECK‐HF registries according to diabetes in patients with a reduced left ventricular ejection fraction. Data from the CHAMP‐HF registry were used with permission.